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Background. Previous studies suggest that obesity may be a risk factor for complications from pandemic
inﬂuenza A(H1N1)infection. We aimed to examine the association between obesity andrespiratory hospitalizations
during seasonal inﬂuenza epidemics and to determine the extent of this association among individuals without
established risk factors for serious complications due to inﬂuenza infection.
Methods. We conducted a cohort study over 12 inﬂuenza seasons (1996–1997 through 2007–2008) of 82545
respondents to population health surveys in Ontario, Canada. We included individuals aged 18–64 years who had
responded to a survey within 5 years prior to the start of an inﬂuenza season. We used logistic regression to examine
the association between self-reported body mass index (BMI) and hospitalization for selected respiratory diseases
(pneumonia and inﬂuenza, acute respiratory diseases, and chronic lung diseases), both in the entire cohort and
stratiﬁed by chronic condition status.
Results. Obese class I (BMI, 30–34.9) (odds ratio [OR], 1.45 [95% conﬁdence interval {CI}, 1.03–2.05]) and
obese class II or III (BMI, $35) individuals (OR, 2.12 [95% CI, 1.45–3.10]) were more likely than normal weight
individuals to have a respiratory hospitalization during inﬂuenza seasons. Among obese class II or III individuals,
the association was present both for those without previously identiﬁed risk factors (OR, 5.10 [95% CI, 2.53–10.24])
and for those with 1 risk factor (OR, 2.11 [95% CI, 1.10–4.06]).
Conclusions. Severely obese individuals with and without chronic conditions are at increased risk for
respiratory hospitalizations during inﬂuenza seasons. They should be considered a priority group for preventive
inﬂuenza measures, such as vaccination and treatment with antiviral medications.
Inﬂuenza causes substantial mortality and serious
morbidity each year [1, 2]. Cardiac and pulmonary
disorders, diabetes mellitus and other metabolic
diseases, cancer, immunosuppression, renal disease, and
anemias are recognized risk factors for serious compli-
cations from inﬂuenza infection [3].
Prior to the 2009 inﬂuenza A(H1N1) pandemic,
obesity had not previously been considered a risk factor
for severe inﬂuenza infection [4]. However, animal
studies suggest that obesity may increase the risk of in-
ﬂuenza complications; compared with lean controls,
diet-induced obese mice have decreased and delayed
expression of proinﬂammatory cytokines, decreased
natural killer cell cytotoxicity, and impaired dendritic
cell function during inﬂuenza infection, resulting in
higher morbidity and mortality from inﬂuenza viruses
[5, 6]. In humans, greater than expected prevalence of
obesity (body mass index [BMI], $30) and morbid
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hospitalized for pandemic H1N1 infection [4, 7–9]. Individuals
with high BMIs are more likely to have conditions that increase
the risk of inﬂuenza complications, including diabetes mellitus
and cardiovascular conditions [10–12], but it is unclear whether
elevated BMI is an independent risk factor.
The prevalence of obesity is 23.1% in Canada and 33.8% in
the United States [13, 14], and obesity rates are increasing, es-
pecially in the higher obesity categories [15]. Although obesity
seems to be a risk factor for severe pandemic H1N1 infection,
the association between obesity and seasonal inﬂuenza has, to
our knowledge, never been studied. Therefore, we sought to
examine the association between obesity and respiratory hos-
pitalizations during seasonal inﬂuenza epidemics (as a proxy for
severe outcomes related to inﬂuenza) and to determine the ex-
tent of this association among individuals without established
risk factors for serious complications due to inﬂuenza. Obese
individuals without other comorbidities have previously not
been considered a priority group for inﬂuenza immunization;
therefore, an association in this group would be relevant for the
determination of public health policy.
METHODS
Population, Setting, and Study Design
We conducted a cohort study of individuals who responded
to one of Canada’s nationally representative cross-sectional
population health surveys conducted by Statistics Canada: the
1996/1997 cycle of the National Population Health Survey
(NPHS), or cycle 1.1 (2000–2001), cycle 2.1 (2003), or cycle 3.1
(2005) of the Canadian Community Health Survey (CCHS)
[16, 17]. Targeting the household population aged $12 years,
these surveys exclude full-time military, institutionalized, and
on-reserve populations. The surveys were conducted using
a combination of telephone and in-person interviews and
had response rates ranging from 75% to 82% for Ontario.
This study was restricted to those who agreed to linkage of
their responses to health administrative data sets and whose
data were linked successfully (linkage rate, 84%); linkage was
achieved using encrypted health card numbers that served as
unique identiﬁers.
We examined outcomes for study subjects over 12 inﬂuenza
seasons (1996–1997 through 2007–2008). Setting the start of
each inﬂuenza season as the index date, we included Ontario
residents aged18–64 yearsonthe index date who had responded
to a survey up to 5 years prior to that date. Therefore, an in-
dividual could be included in the cohort up to 5 times. Sensi-
tivity analyses were conducted excluding repeated cohort
entries. Women who were pregnant or breastfeeding at the time
of survey (n 5 2115) and individuals with a height of ,3f e e t
or $7f e e t( n 5 39) were excluded, because Canadian guidelines
do not recommend BMI calculation in such individuals [18].
We also identiﬁed women who became pregnant during sub-
sequent inﬂuenza seasons by extracting hospital admission dates
for births for all women in the cohort and excluding for the
relevantinﬂuenzaseasonswomenwhohadabirthrecordduring
an inﬂuenza season or within 40 weeks following the end of an
inﬂuenza season (4785 inﬂuenza seasons of observation), be-
cause theprepregnancyBMImeasuredatthe timeofsurveymay
not have been reﬂective of BMI during pregnancy.
All cohort members had free access to hospital care and
physician services, and starting in fall 2000, with the in-
troduction of universal inﬂuenza immunization in Ontario, all
were able to receive the inﬂuenza vaccine free of charge re-
gardless of risk status. Ethics approval was obtained from the
Research Ethics Board of Sunnybrook Health Sciences Centre,
Toronto, Canada.
Data Sources and Definitions
Inﬂuenza Seasons and Control Periods
We obtained laboratory test results for inﬂuenza (mainly viral
culture and direct antigen detection) submitted by a network of
sentinel laboratories to the Public Health Agency of Canada.
Two study periods were deﬁned: (1) inﬂuenza seasons, deﬁned
as the period between the ﬁrst and last occurrences of 2 con-
secutive weeks with $5% of inﬂuenza tests yielding positive
results, corresponding to the start and end dates of the inﬂuenza
season; and (2) post–inﬂuenza season periods (control periods),
deﬁned as July 1–September 30 annually. In a sensitivity anal-
ysis, we deﬁned inﬂuenza seasons using a 10% threshold.
Body Mass Index
BMI was calculated using self-reported height and weight from
the NPHS or CCHS. In general, there is high correlation be-
tween self-reported and measured height and weight [19];
however, people tend to underestimate weight and overestimate
height, causing reported BMI to be generally lower than mea-
sured BMI [19–21]. Measured BMI is not available from these
surveys but was available in CCHS cycle 2.2. That cycle was not
included in this study, because it has not been linked to health
administrative data sets. In that sample (N 5 1131), self-re-
ported BMI reliably predicted measured BMI for individuals
aged 20–64 years (r 5 0.93). BMI categories were deﬁned using
Health Canada’s Guidelines for Body Weight Classiﬁcation in
Adults: ,18.5 (underweight), 18.5–24.9 (normal weight), 25.0–
29.9 (overweight), 30.0–34.9 (obese class I), 35.0–39.9 (obese
class II), and $40 (obese class III) [18]. Because of the small
number of individuals in the obese class II and III categories,
these were collapsed.
Main Outcome Measure
The primary outcome was hospitalization for the following re-
spiratory diseases: pneumonia and inﬂuenza (International
Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation
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Diseases, Tenth Revision, Clinical Modiﬁcation [ICD-10-CM]
codes, J10–J18), acute respiratory infections (ICD-9-CM codes,
460–466; ICD-9-CM codes, J00–J06, J20–J22), and chronic lung
disease (ICD-9-CM codes, 490–496; ICD-10-CM codes, J40–
J47). Although not as speciﬁc as hospitalization with laboratory
conﬁrmation of inﬂuenza, these conditions have been used
previously in studies of inﬂuenza-associated hospitalizations
[22, 23]. The study protocol required 1 of these conditions to
be coded as an admitting cause for the hospitalization. Hos-
pitalizations were ascertained using the Canadian Institute of
Health Information (CIHI) Discharge Abstract database, which
contains detailed information on diagnoses and procedures for
admissions to all acute care hospitals [24]. Only the ﬁrst hos-
pitalization for each patient was considered for each inﬂuenza
season. To examine the association between BMI and more
severe illness, we used respiratory hospitalizations that also
involved admission to an intensive care unit (ICU) in
a sensitivity analysis [25]. Information concerning ICU visits
was not available before 2002; therefore, we restricted this
sensitivity analysis to the 2002–2003 through 2007–2008 in-
ﬂuenza seasons.
Covariates
Demographic information (age, sex, neighborhood income
quintile, and rural residence) was obtained from Ontario’s
Registered Persons Database, which contains key demographic
data about anyone with an Ontario health card [26]. Neigh-
borhood income quintiles were deﬁned by using patients’ postal
codes to assign them to geographic regions where the average
annual income could be determined through linkage to census
data [27]. Responses from the health surveys were used to de-
termine an individual’s smoking status (current daily smoker or
not) and the number of individuals residing in the respondent’s
household. Previous health care utilization was assessed using
the Ontario Health Insurance Plan (OHIP) physician billing
claims database (outpatient clinic visits during the past year),
which contains claims for outpatient clinic visits from approxi-
mately 98% of Ontario physicians [28], and the CIHI discharge
abstract database (hospital visits during the previous 3 years).
Inﬂuenza vaccination status was assessed using the OHIP
database. Individuals vaccinated after the start of an inﬂuenza
season were considered unvaccinated, although only 5% of
vaccines were administered after the onset of inﬂuenza seasons.
Comorbidities were deﬁned on the basis of an adaptation of
the adjusted clinical group classiﬁcation as any mention of the
diagnosis in the outpatient or hospitalization data sets during
the 3 years prior to an index date [29]. The comorbidities of
interest were the chronic health conditions identiﬁed by
Canada’s National Advisory Committee on Immunizations
(NACI) as increasing the risk of complications from inﬂuenza
(heart diseases, respiratory diseases, diabetes mellitus, cancers,
immunodeﬁciency due to underlying disease and/or therapy,
renal diseases, anemias, and aspiration history) [3]. Because
individualscouldhavebeenincludedmultiple times,weupdated
covariate information at each index date.
Statistical Analyses
We ﬁtted logistic regression models to estimate the risk of
hospitalization during inﬂuenza seasons among BMI categories,
with normal weight individuals as the referent. In an adjusted
analysis, covariates were added to the models. Because in-
dividuals with comorbidities were already recommended to
receive inﬂuenza vaccines regardless of BMI, we also conducted
a stratiﬁed analysis in which we divided the cohort into
individuals without any NACI-recognized comorbidities asso-
ciatedwithincreasedriskofinﬂuenzacomplications,individuals
with 1 NACI-recognized risk factor, and individuals with
$2 risk factors.
To test the robustness of our ﬁndings, we conducted multiple
sensitivity analyses. To determine the underlying propensity for
individuals in different weight categories to be hospitalized, we
assessed the association between BMI and hospitalization for
any cause during inﬂuenza seasons. To test for the lack of an
association where none was expected (ie, speciﬁcity), we ex-
amined the association between BMI category and hospitaliza-
tion for external causes of injury (ICD-9-CM codes, E800–E999;
ICD-10-CM codes, V01–Y98) during inﬂuenza seasons, and we
assessed the association between the main outcome conditions
(ie, respiratory conditions) during control periods when
inﬂuenza was not circulating.
Because an individual could have been included in the anal-
ysis up to 5 times, we used generalized estimating equations
to adjust for the correlated nature of the data. Statistical anal-
yses were conducted using SAS, version 9.1 (SAS Institute), and
STATA, version 9.2 (StataCorp). All tests were 2-tailed, and
a P value of ,.05 was considered to reveal a statistically signif-
icant difference.
RESULTS
The cohort comprised 82545 unique survey responders who
were included for a total of 348350 person-seasons and who
contributed 105035.6 person-years of observation during in-
ﬂuenza seasons. A total of 372 hospitalizations occurred during
inﬂuenza seasons, and 288 hospitalizations occurred during
control periods. Weekly outcome rates during the study period
revealed seasonality, with spikes coinciding with periods of in-
ﬂuenza activity (Figure 1). The prevalence of having $1h i g h -
risk comorbidity for inﬂuenza was 27%.
Approximately 46% of the cohort self-reported a normal
body weight, 2.4% reported a BMI ,18.5, 33% reported a BMI
of 25–29.9, 12% reported a BMI of 30–34.9, and 5% reported
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were older, had lower socioeconomic status, were more likely to
live in rural areas, were less likely to smoke daily, had more
outpatient visits, and were more likely to receive inﬂuenza
vaccination. They also had more risk factors for inﬂuenza
complications, particularly for chronic cardiovascular diseases,
chronic respiratory diseases, and diabetes mellitus; 44% in the
highest BMI categoryhad$ 1riskfactor,comparedwith23%in
the normal BMI category.
Increased BMI was associated with greater odds of respiratory
hospitalizations during inﬂuenza seasons (Table 2). In the ad-
justed analysis, individuals who were obese class I (odds ratio
[OR], 1.45 [95% conﬁdence interval {CI}, 1.03–2.05]) and
individuals who were obese class II or III (OR, 2.12 [95% CI,
1.45–3.10]) had signiﬁcantly higher odds of the outcome during
inﬂuenza seasons. Adjustment for confounders attenuated the
observed ORs for the higher BMI categories. Similar results
were seen when stratifying the cohort by the presence of
comorbidities known to increase risk for serious inﬂuenza
outcomes. The point estimate for the odds ratio among obese
class II or III individuals was larger for those without risk
factors (OR, 5.10 [95% CI, 2.53–10.24]), compared with those
with only 1 risk factor (OR, 2.11 [95% CI, 1.10–4.06]) and
those with $2 risk factors (OR, 1.66 [95% CI, 0.97–2.84]), but
the conﬁdence intervals overlapped. The event rate for obese
class II or III individuals without risk factors was similar to
the event rate for normal weight individuals with 1 risk factor
(3.97 events per 1000 person-years vs 4.07 events per 1000
person-years).
Obese class II or III individuals also had greater odds of re-
spiratory hospitalizations resulting in admission to an ICU
during the 2002–2003 through 2007–2008 inﬂuenza seasons
(OR, 3.23 [95% CI, 1.24–8.45]) (Table 3). Obese individuals
were more likely to be hospitalized for any cause during in-
ﬂuenza seasons. There was no association between BMI and
hospitalization for external causes of injury during inﬂuenza
seasons. Also, we observed no association between BMI and
hospitalization for selected respiratory conditions during con-
trol periods, except for the underweight category. When the
cohort was restricted to the ﬁrst appearance of each individual,
and when inﬂuenza seasons were deﬁned usinga 10%threshold,
the results were generally consistent with those of the primary
analysis.
DISCUSSION
We found obesity (BMI, $30) to be independently associated
with an increased risk of respiratory hospitalizations during
periods of seasonal inﬂuenza activity. The association between
severe obesity (BMI, $35) and respiratory hospitalizations was
presentbothfor those without previously recognized risk factors
for serious inﬂuenza complications and for those with 1 risk
factor. In addition, severely obese individuals without risk fac-
tors had an event rate similar to that of normal weight in-
dividuals with only 1 risk factor, indicating that severe obesity
may be as important a predictor of inﬂuenza complications as
are other identiﬁed chronic conditions. We also observed
a similar association using ICU admissions as an outcome.
Figure 1. Weekly trends of influenza viral surveillance and rates of hospitalizations for selected respiratory conditions. The weekly hospitalization rate
for selected respiratory conditions is indicated by a solid black line, the weekly percentage of tests positive for influenza is represented by gray regions,
and influenza seasons are denoted by vertical gray dashed lines. The x-axis indicates 7 September of each year of the study period.
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tion from any cause during inﬂuenza season, the association was
greater for respiratory conditions than for other conditions.
Additional sensitivity analyses revealed speciﬁcity and consis-
tency of the association.
This study examines the relationship between obesity and
respiratory hospitalizations during seasonal inﬂuenza epi-
demics. Previous studies have revealed a high prevalence of
obesity among individuals with complications of pandemic
H1N1 infection [4, 7–9]. Furthermore, a recent case-cohort
study reported that morbidly obese individuals (BMI, $40) had
a 4–5 times greater risk of hospitalization for H1N1 than did
normal weight individuals [30]. Our study found a smaller as-
sociation between severe obesity (BMI, $35) and hospitaliza-
tion, and we detected an increase in risk for obese individuals in
addition to morbidly obese individuals. Differences in the study
Table 1. Baseline Characteristics by Body Mass Index (BMI) Group
Characteristic
No. (%) of person-seasons
Underweight
BMI , 18.5
(n 5 8400
[2.4%])
Normal
BMI 18.5–24.9
(n 5 158897
[45.6%])
Overweight
BMI 25.0–29.9
(n 5 115342
[33.1%])
Obese class I
BMI 30.0–34.9
(n 5 42268
[12.1%])
Obese class II
and III BMI $35
(n 5 16366
[4.7%])
Age, mean years (SD) 35.2 (12.3) 40.9 (12.5) 45.3 (11.7) 46.2 (11.6) 46.4 (11.3)
Age group, years
18–29 3559 (42.4) 37722 (23.7) 13435 (11.7) 4181 (9.9) 1514 (9.3)
30–49 3632 (43.2) 79369 (50.0) 57300 (49.7) 20398 (48.3) 7867 (48.1)
50–64 1209 (14.4) 41806 (26.3) 44607 (38.7) 17689 (41.9) 6985 (42.7)
Male sex 1651 (19.7) 67020 (42.2) 70294 (60.9) 23749 (56.2) 6855 (41.9)
Income quintile
1 (lowest) 2053 (24.4) 29014 (18.3) 20648 (17.9) 8639 (20.4) 3952 (24.2)
2 1564 (18.6) 31322 (19.7) 22855 (19.8) 8487 (20.1) 3630 (22.2)
3 1616 (19.2) 31551 (19.9) 23779 (20.6) 8922 (21.1) 3347 (20.5)
4 1552 (18.5) 32196 (20.3) 23779 (20.6) 8524 (20.2) 2863 (17.5)
5 (highest) 1507 (17.9) 32746 (20.6) 23025 (20.0) 7363 (17.4) 2461 (15.0)
No data 108 (1.3) 2068 (1.3) 1256 (1.1) 333 (0.8) 113 (0.7)
Rural residence
Yes 1306 (15.6) 30514 (19.2) 25474 (22.1) 10288 (24.3) 4064 (24.8)
No 6996 (83.3) 126592 (79.7) 88874 (77.1) 31741 (75.1) 12225 (74.7)
No data 98 (1.2) 1791 (1.1) 994 (0.9) 239 (0.6) 77 (0.5)
No. of individuals living in household,
mean (SD)
3.0 (1.5) 2.9 (1.4) 2.8 (1.4) 2.7 (1.4) 2.6 (1.4)
Current daily smoker 3111 (37.0) 44040 (27.7) 28097 (24.4) 9703 (23.0) 3549 (21.7)
No. of outpatient visits in
past year, mean (SD)
7.6 (10.0) 6.6 (9.1) 6.9 (9.2) 8.3 (10.4) 10.4 (12.6)
No. of hospitalizations in
past 3 years, mean (SD)
0.2 (0.8) 0.2 (0.6) 0.2 (0.6) 0.2 (0.7) 0.3 (0.9)
Vaccinated against inﬂuenza 948 (11.3) 19277 (12.1) 16756 (14.5) 7346 (17.4) 3570 (21.8)
Risk factors for inﬂuenza
complications
a
Chronic cardiovascular diseases 388 (4.6) 8079 (5.1) 8969 (7.8) 4110 (9.7) 2005 (12.3)
Chronic respiratory diseases 964 (11.5) 15634 (9.8) 11740 (10.2) 5255 (12.4) 2806 (17.2)
Diabetes mellitus 122 (1.5) 3763 (2.4) 6575 (5.7) 4896 (11.6) 3421 (20.9)
Cancers 309 (3.7) 7677 (4.8) 6377 (5.5) 2462 (5.8) 943 (5.8)
Anemias 504 (6.0) 6474 (4.1) 3546 (3.1) 1493 (3.5) 780 (4.8)
Renal diseases 72 (0.9) 1280 (0.8) 1257 (1.1) 593 (1.4) 314 (1.9)
Immunodeﬁciency
(due to disease and/or therapy)
144 (1.7) 2459 (1.6) 1732 (1.5) 712 (1.7) 310 (1.9)
Aspiration history 57 (0.7) 757 (0.5) 853 (0.7) 280 (0.7) 156 (1.0)
$1 Risk factor 1960 (23.3) 36694 (23.1) 31378 (27.2) 14427 (34.1) 7259 (44.4)
NOTE. Data are no. (%) of patients unless otherwise speciﬁed.
a Chronic conditions identiﬁed by Canada’s National Advisory Committee on Immunizations as increasing the risk of complications from inﬂuenza.
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ures, and study designs may explain some of the discrepancies.
This study had several limitations. BMI was based on self-
reported height and weight, rather than direct measurement.
Nevertheless, we showed that self-reported BMI reliably pre-
dicted measured BMI for this population. Any misclassiﬁcation
would be minor and, if present, would tend to underestimate
our associations. Another limitation is that because individuals
were included if they had completed a survey within 5 years of
an inﬂuenza season, it is possible that their BMI may have
changed over the study period. Data from the longitudinal
NPHSsuggeststhatBMI increasesonaverage only0.5 units over
a 6-year period [31]. Such a small increase would have resulted
in minimal misclassiﬁcation of individuals to BMI categories in
the years following survey response in this study. The selected
respiratory hospitalizations during periods of inﬂuenza circu-
lation used as the outcome measure in this study were non-
speciﬁc and may have been due to causes other than inﬂuenza.
However, they correlate well with inﬂuenza circulation and have
been used in previous studies [22, 23]. We lacked sufﬁcient
event counts to adequately examine risk of outcomes in
individuals without chronic conditions, as evidenced by the
wider conﬁdence intervals. Ontario’s universal inﬂuenza
immunization program facilitates access to inﬂuenza vaccines
through workplaces and community settings; thus, not all
vaccination is captured by physician billing data [32]. This may
lead to misclassiﬁcation of vaccination status. However, using
self-reported vaccination as the gold standard, a physician bill-
ing claim for inﬂuenza vaccination had a positive predictive
value of 0.89 and a negative predictive value of 0.81 for the
age group in this study. Another limitation is that covariates
derived from responses to the health surveys (smoking status
and number of individuals living in household) may have
changed over the study period and could not be updated at each
index date. Finally, we were unable to distinguish whether
obesity was associated with increased risk of inﬂuenza infection
Table 2. Associations Between BMI Category and Hospitalization for Selected Respiratory Conditions (Adjusted and Stratified
Analyses)
BMI category Event rate per 1000 person-years
OR (95% CI)
Unadjusted Adjusted
a
Entire cohort 3.54
,18.5 (underweight) 5.54 2.27 (1.21–4.23) 1.65 (0.88–3.08)
18.5–24.9 (normal weight) 2.49 1.00 1.00
25–29.9 (overweight) 2.88 1.16 (0.87–1.55) 1.02 (0.75–1.37)
30–34.9 (obese class I) 5.43 2.15 (1.54–3.01) 1.45 (1.03–2.05)
$35 (obese class II or III) 11.60 4.73 (3.28–6.82) 2.12 (1.45–3.10)
Without risk factors 0.93
,18.5 (underweight) 0.51 0.73 (0.10–5.38) 0.89 (0.12–6.72)
18.5–24.9 (normal weight) 0.71 1.00 1.00
25–29.9 (overweight) 0.79 1.12 (0.63–2.01) 0.98 (0.55–1.77)
30–34.9 (obese class I) 1.43 2.03 (1.02–4.02) 1.73 (0.86–3.46)
$35 (obese class II or III) 3.97 5.68 (2.81–11.50) 5.10 (2.53–10.24)
With 1 risk factor
b 4.89
,18.5 (underweight) 8.63 2.10 (0.75–5.92) 1.62 (0.54–4.83)
18.5–24.9 (normal weight) 4.07 1.00 1.00
25–29.9 (overweight) 4.14 1.02 (0.63–1.67) 1.04 (0.63–1.72)
30–34.9 (obese class I) 5.98 1.51 (0.85–2.70) 1.48 (0.83–2.65)
$35 (obese class II or III) 9.49 2.40 (1.25–4.60) 2.11 (1.10–4.06)
With $2 risk factors
b 29.10
,18.5 (underweight) 73.15 2.96 (1.28–6.86) 2.15 (0.92–5.07)
18.5–24.9 (normal weight) 25.98 1.00 1.00
25–29.9 (overweight) 22.50 0.86 (0.56–1.33) 0.94 (0.59–1.48)
30–34.9 (obese class I) 30.20 1.16 (0.72–1.88) 1.18 (0.72–1.94)
$35 (obese class II or III) 43.58 1.83 (1.09–3.09) 1.66 (0.97–2.84)
NOTE. CI, conﬁdence interval; OR, odds ratio.
a All models were adjusted for age group, sex, inﬂuenza vaccination status, rural residence, income quintile, number of individuals living in the household,
smoking status, previous hospitalizations during past 3 years, and previous outpatient visits during past year. In the nonstratiﬁed analysis, models were also
adjusted for chronic cardiovascular disease, chronic respiratory disease, diabetes mellitus, cancer, anemia, renal disease, immunodeﬁciency, and aspiration history.
b Chronic conditions identiﬁed by Canada’s National Advisory Committee on Immunizations as increasing the risk of complications from inﬂuenza.
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inﬂuenza infection.
Among the strengths of this study, the most notable was our
ability to link population-based BMI data for a large number of
individuals to health administrative data sets to determine
outcomes, vaccination status, and comorbidities. This afforded
a unique opportunity to study this association. Furthermore, we
studied multiple inﬂuenza seasons, and we used inﬂuenza viral
surveillance data to deﬁne periods of inﬂuenza activity. Future
research should use laboratory-conﬁrmed inﬂuenza outcomes
and objective measures of height and weight, although it may
not be feasible to collect such data on a sufﬁciently large
population to examine serious complications from inﬂuenza.
Obesity is recognized as an important and growing public
health problem because of its association with many serious
chronic conditions. This study offers a new perspective on the
Table 3. Sensitivity Analyses
Outcome Event rate per 1000 person-years OR
a (95% CI)
Respiratory hospitalizations resulting in admission to an
Intensive care unit (2002/2003 through 2007/2008 inﬂuenza seasons only)
0.67
,18.5 (underweight) 1.64 3.27 (0.76–14.15)
18.5–24.9 (normal weight) 0.29 1.00
25–29.9 (overweight) 0.75 2.21 (0.98–4.96)
30–34.9 (obese class I) 0.83 1.88 (0.72–4.94)
$35 (obese class II or III) 2.78 3.23 (1.24–8.45)
All hospitalizations during inﬂuenza seasons 47.89
,18.5 (underweight) 40.34 0.96 (0.77–1.20)
18.5–24.9 (normal weight) 39.54 1.00
25–29.9 (overweight) 48.46 1.09 (1.02–1.17)
30–34.9 (obese class I) 63.14 1.20 (1.09–1.31)
$35 (obese class II or III) 88.77 1.42 (1.26–1.60)
Hospitalizations for external causes of
injury during inﬂuenza seasons
9.64
,18.5 (underweight) 8.70 0.90 (0.58–1.41)
18.5–24.9 (normal weight) 8.39 1.00
25–29.9 (overweight) 9.72 1.08 (0.92–1.26)
30–34.9 (obese class I) 11.99 1.12 (0.91–1.38)
$35 (obese class II or III) 15.59 1.22 (0.93–1.59)
Respiratory hospitalizations during control periods 3.41
,18.5 (underweight) 7.86 2.18 (1.24–3.84)
18.5–24.9 (normal weight) 2.73 1.00
25–29.9 (overweight) 3.18 1.06 (0.76–1.47)
30–34.9 (obese class I) 4.28 1.07 (0.71–1.60)
$35 (obese class II or III) 6.28 0.99 (0.60–1.65)
Respiratory hospitalizations during inﬂuenza seasons,
cohort restricted to ﬁrst appearance of individual in data set
3.60
,18.5 (underweight) 5.60 1.53 (0.41–5.81)
18.5–24.9 (normal weight) 2.21 1.00
25–29.9 (overweight) 2.88 1.10 (0.59–2.03)
30–34.9 (obese class I) 4.47 1.33 (0.64–2.77)
$35 (obese class II or III) 16.13 2.97 (1.48–5.94)
Respiratory hospitalizations during inﬂuenza seasons,
using 10% of inﬂuenza tests yielding positive results as the threshold
4.06
,18.5 (underweight) 6.15 1.53 (0.73–3.21)
18.5–24.9 (normal weight) 2.99 1.00
25–29.9 (overweight) 3.35 0.96 (0.68–1.35)
30–34.9 (obese class I) 5.46 1.20 (0.81–1.78)
$35 (obese class II or III) 13.68 1.98 (1.29–3.04)
NOTE. CI, conﬁdence interval; OR, odds ratio.
a All models were adjusted for age group, sex, inﬂuenza vaccination status, rural residence, income quintile, number of individuals living in the household,
smoking status, previous hospitalizations during past 3 years, previous outpatient visits during past year, and the presence of chronic cardiovascular disease, chronic
respiratory disease, diabetes mellitus, cancer, anemia, renal disease, immunodeﬁciency, and aspiration history.
Obesity and Inﬂuenza Hospitalization d CID 2011:53 (1 September) d 419dangers of obesity and its relationship to severe inﬂuenza in-
fection. The results of this study suggest that severe obesity is
associated with an increased risk of respiratory hospitalizations
during inﬂuenza season, although this relationship may vary
(ie, be stronger or weaker) in future years, with new inﬂuenza
strains and different circumstances. To minimize this risk, severely
obese individuals should be recommended to receive annual in-
ﬂuenza vaccination and be considered for treatment with antiviral
medications if they present with inﬂuenza-like illness during
periods of inﬂuenza circulation. In the presence of universal
inﬂuenza immunization, obese individuals should be prioritized
to receive vaccine. Public health and clinical interventions to
reduce the prevalence of obesity in the population may also reduce
the annual health and economic burden of inﬂuenza.
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